ARCHIMED’s MED II fund successfully exits EUROLyser with a sixfold return, marking a significant milestone in the healthcare investment landscape.

Information on the Target

EUROLyser, founded in 2005 and located in Salzburg, Austria, specializes in the design and engineering of patented point-of-care testing equipment and diagnostic kits for both animals and humans. The company focuses on providing rapid and reliable diagnostic solutions that facilitate immediate availability of test results during consultations. This innovative approach aids healthcare professionals in making timely and informed treatment decisions, thereby enhancing patient outcomes.

With a commitment to advancing diagnostic technology, EUROLyser has established itself as a key player in the point-of-care diagnostics sector. The company has experienced significant growth since its inception, supported by its focus on developing user-friendly testing solutions that cater to a diverse range of medical conditions.

Industry Overview in Austria

The healthcare sector in Austria is characterized by a robust system that emphasizes high-quality medical services and technological advancements. The point-of-care diagnostics industry has gained traction within this